Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 4198

Original article / research
Year : 2017 | Month : August | Volume : 11 | Issue : 8 | Page : EC12 - EC15

CD44 Expression in Meningioma and its Correlation with Proliferation Indices

Rasha Ramadan Mostafa, Rasha Ahmed Khairy

1. Lecturer, Department of Pathology, Faculty of Medicine, Cairo University, Egypt. 2. Lecturer, Department of Pathology, Faculty of Medicine, Cairo University, Egypt.

Correspondence Address :
Dr. Rasha Ahmed Khairy,
119 Al Ahram Street, Giza, Egypt.
E-mail: rasha.jawad@kasralainy.edu.eg

Abstract

Introduction: CD44 is a cell adhesion molecule assumed to be related to tumour invasion and metastatic ability and is expressed in variety of tumours including meningiomas.

Aim: To evaluate the immunohistochemical expression of CD44 in variable grades and variants of meningioma and to correlate the results with Ki-67 proliferation index and available clinicopathologic variables.

Materials and Methods: A total of 40 meningioma cases were studied for immunohistochemical expression of CD44 and Ki-67 and correlated with different clinicopathologic variables. A p-value less than 0.05 was considered statistically significant.

Results: CD44 was markedly expressed in high grade (II and III) meningioma (81.8%) compared to grade I (18.2%) and that was statistically significant (p<0.001). Ki-67 proliferation activity was significantly correlated with meningioma grade (p<0.001) and brain invasiveness (p=0.033). Moreover, statistically positive correlation (p=0.01) was reported between CD44 and Ki-67 proliferative activity. No statistically significant correlation was detected between CD44 or Ki-67 expression and patients’ age, sex, and tumour recurrence rate (p>0.05).

Conclusion:We concluded that CD44 is a marker of aggressiveness in meningioma as it was significantly highly expressed in grade II and III meningioma and was, positively correlated with higher Ki-67 proliferation indices. Therefore, researches should be carried out to identify the role of CD44 targeted therapy in atypical and anaplastic meningiomas as done in other tumours e.g., breast cancer.

Keywords

Immunohistochemical, Ki-67, Meningioma

How to cite this article :

Rasha Ramadan Mostafa, Rasha Ahmed Khairy. CD44 EXPRESSION IN MENINGIOMA AND ITS CORRELATION WITH PROLIFERATION INDICES. Journal of Clinical and Diagnostic Research [serial online] 2017 August [cited: 2017 Aug 20 ]; 11:EC12-EC15. Available from
http://jcdr.net/back_issues.asp?issn=0973-709x&year=2017&month=August&volume=11&issue=8&page=EC12-EC15&id=10379

DOI and Others

DOI: 10.7860/JCDR/2017/28438.10379

Date of Submission: Mar 27, 2017
Date of Peer Review: Apr 25, 2017
Date of Acceptance: May 15, 2017
Date of Publishing: Aug 01, 2017

FINANCIAL OR OTHER COMPETING INTERESTS: None.

JCDR is now Monthly and more widely Indexed .
  • PubMed Central® (PMC)New
  • Academic Search Complete Database
  • Chemical Abstracts Service
  • Directory of Open Access Journals (DOAJ)
  • EBSCOhostNew
  • Embase & EMbiology
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Open J-Gate
  • Popline (reproductive health literature)
  • SCOPUS
  • www.omnimedicalsearch.com